EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma

Yichao Bu, Run Huang, Jun Gao, Weifeng Qu, Xiutao Fu, Weiren Liu, Zhenbin Ding, Jian Zhou, Jia Fan, Xin Wang, Diyu Chen, Zheng Tang

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.13901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Yichao Bu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cell Transformation, Neoplastic, Exome Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMs Innovation Fund for Medical sciences, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular adenoma (HCA) represents a rare benign hepatic neoplasm with potential for malignant transformation into hepatocellular carcinoma (HCC), yet the underlying mechanism remains elusive. In this study, we investigated the genomic landscape of this process to identify therapeutic strategies for blocking malignant transformation. Using micro‐detection techniques, we obtained specimens of adenoma, cancerous neoplasm and adjacent normal liver from three patients undergoing hepatic resection surgery. Whole‐exome sequencing (WES) was performed, and genomic interactions between HCA and HCC components within the same tumour were evaluated using somatic variant calling, copy number variation (CNV) analysis, clonality evaluation and mutational signature analysis. Our results revealed genomic heterogeneity among patient cases, yet within each sample, HCA and HCC tissues exhibited a similar mutational landscape, suggesting a high degree of homology. Using nonnegative matrix factorization and phylogenetic trees, we identified shared and distinct mutational characteristics and uncovering necessary pathways associated with HCA–HCC malignant transformation. Remarkably, we found that HCA and HCC shared a common monoclonal origin while displaying significant genetic diversity within HCA–HCC tumours, indicating fundamental genetic connections or evolutionary pathways between the two. Moreover, elevated immune therapy‐related markers in these patients suggested heightened sensitivity to immune therapy, providing novel avenues for the treatment of hepatic malignancies. This study sheds light on the genetic mechanisms underlying HCA–HCC progression, offering potential targets for therapeutic intervention and highlighting the promise of immune‐based therapies in managing hepatic malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularCell Transformation, NeoplasticExome SequencingMutationAdenoma, Liver CellHumansMaleFemaleDNA Copy Number VariationsMiddle AgedDNA Mutational Analysis

Stichwörter der Autor:innen

genomic landscapehepatocellular adenomamalignant transformationmutational signaturewhole‐exome sequencing

Autor:innen und Institutionen

  • Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai, China.
  • Department of Thyroid and Breast Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

Förderung

  • CAMs Innovation Fund for Medical sciences
  • Shanghai Municipal Health Commission

Zitieren

APA

Bu, Y., Huang, R., Gao, J., Qu, W., Fu, X., Liu, W., Ding, Z., Zhou, J., Fan, J., Wang, X., Chen, D., & Tang, Z. (2024). Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13901

Vancouver

Bu Y, Huang R, Gao J, Qu W, Fu X, Liu W, et al. Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.13901

BibTeX
@article{Bu2024,
  author = {Bu, Yichao and Huang, Run and Gao, Jun and Qu, Weifeng and Fu, Xiutao and Liu, Weiren and Ding, Zhenbin and Zhou, Jian and Fan, Jia and Wang, Xin and Chen, Diyu and Tang, Zheng},
  title = {Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.13901}
}
Kostenlos starten →